Mastering Moving Averages.
Optimism surrounding positive results from Moderna’s COVID-19 vaccine boosted sentiment and the Price of the VVC/CA finished the week higher. Overall, it gained $0.40 per share over the last five trading days to close at $23.60 per share, a new all-time closing high. However, while the Price of the VVC/CA moved…